3.660USD-3.43%Mkt Cap: 291.50M USDP/E: 17.43Last update: 2026-05-22
Niagen Bioscience, Inc. operates as a bioscience company engages in developing healthy aging products. The company operates through Consumer products; Ingredients; and Pharmaceutical Segments. It provides finished dietar…
Industry Peers
Biotechnologyloading…
Indicators:|
Key Statistics
Company
Market Cap291.50M USD
Enterprise Value238.66M USD
Revenue (TTM)130.42M USD
Gross Profit83.19M USD
Net Income (TTM)17.38M USD
Revenue/Share1.636 USD
Last Price3.660 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees117
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)17.43
P/E (Forward)11.84
PEG—
EV/EBITDA19.92
EV/Revenue1.83
P/S2.31
P/B3.67
EPS (TTM)0.21
EPS (Forward)0.32
52W Range
3.5701% of range14.69
52W High14.69 USD
52W Low3.570 USD
Profitability
Gross Margin64.28%
Oper. Margin5.01%
EBITDA Margin9.19%
Profit Margin13.43%
ROE22.71%
ROA16.34%
Growth
Revenue Growth3.30%
Earnings Growth16.70%
Cash Flow & Leverage
Operating CF13.50M USD
CapEx (TTM)292.00K USD
FCF Margin-1.43%
FCF Yield-0.64%
Net Debt-63.82M USD
Net Debt/EBITDA-5.33
Balance Sheet
Debt/Equity0.04
Current Ratio4.61
Quick Ratio3.48
Book Value/Sh1.034 USD
Cash/Share0.8320 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:3
Split DateApr 13, 2016
Analyst Consensus
Rating1.0 (Strong Buy)
Target (Mean)12.60 USD
Target Range10.00 USD – 18.00 USD
# Analysts5
Ownership
Shares Out.79.64M
Float52.43M
Insiders29.25%
Institutions47.52%
Short Interest
Short Ratio8.1d
Short % Float10.41%
Short % Out.6.78%
Shares Short5.40M
Short (prev mo.)5.50M
Technical
SMA 504.495 (-18.6%)
SMA 2006.578 (-44.4%)
Beta2.17
S&P 52W Chg28.31%
Avg Vol (30d)916.30K
Avg Vol (10d)1.16M
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—